01.06.2007 | Review
Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (γ-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1 −/− mice and characterization of γ-hydroxybutyric acid pharmacology
Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 3/2007
Einloggen, um Zugang zu erhalten